Kyverna Therapeutics (KYTX) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-20.54
-13.91
-7.29
-0.67

Details

Expected EPS
-0.698318
Actual EPS
-0.67
Surprise EPS
0.03
Surprise Percent
+4.06%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -0.67 per share for Q3 2024.

0 Comments

Share your thoughts